JP2005501082A5 - - Google Patents

Download PDF

Info

Publication number
JP2005501082A5
JP2005501082A5 JP2003518614A JP2003518614A JP2005501082A5 JP 2005501082 A5 JP2005501082 A5 JP 2005501082A5 JP 2003518614 A JP2003518614 A JP 2003518614A JP 2003518614 A JP2003518614 A JP 2003518614A JP 2005501082 A5 JP2005501082 A5 JP 2005501082A5
Authority
JP
Japan
Prior art keywords
aerosol pharmaceutical
pentafluorooctyl
oxy
acetic acid
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003518614A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005501082A (ja
Filing date
Publication date
Priority claimed from GB0118994A external-priority patent/GB0118994D0/en
Priority claimed from GB0206892A external-priority patent/GB0206892D0/en
Application filed filed Critical
Priority claimed from PCT/GB2002/003586 external-priority patent/WO2003013610A2/en
Publication of JP2005501082A publication Critical patent/JP2005501082A/ja
Publication of JP2005501082A5 publication Critical patent/JP2005501082A5/ja
Pending legal-status Critical Current

Links

JP2003518614A 2001-08-03 2002-08-02 界面活性剤化合物およびその使用 Pending JP2005501082A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0118994A GB0118994D0 (en) 2001-08-03 2001-08-03 Compounds
GB0206892A GB0206892D0 (en) 2002-03-23 2002-03-23 Compounds
PCT/GB2002/003586 WO2003013610A2 (en) 2001-08-03 2002-08-02 Surfactant compounds and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005206725A Division JP2006008695A (ja) 2001-08-03 2005-07-15 界面活性剤化合物およびその使用

Publications (2)

Publication Number Publication Date
JP2005501082A JP2005501082A (ja) 2005-01-13
JP2005501082A5 true JP2005501082A5 (https=) 2006-01-05

Family

ID=26246403

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003518614A Pending JP2005501082A (ja) 2001-08-03 2002-08-02 界面活性剤化合物およびその使用
JP2005206725A Pending JP2006008695A (ja) 2001-08-03 2005-07-15 界面活性剤化合物およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005206725A Pending JP2006008695A (ja) 2001-08-03 2005-07-15 界面活性剤化合物およびその使用

Country Status (20)

Country Link
US (1) US7195752B2 (https=)
EP (2) EP1411896B1 (https=)
JP (2) JP2005501082A (https=)
KR (1) KR20040025738A (https=)
CN (1) CN1279893C (https=)
AT (2) ATE373469T1 (https=)
AU (1) AU2002321422B2 (https=)
BR (1) BR0211656A (https=)
CA (1) CA2456052A1 (https=)
CO (1) CO5550416A2 (https=)
DE (2) DE60210102T2 (https=)
ES (2) ES2293157T3 (https=)
HU (1) HUP0401194A2 (https=)
IL (1) IL160114A0 (https=)
MX (1) MXPA04001049A (https=)
NO (1) NO20040462L (https=)
NZ (1) NZ530828A (https=)
PL (1) PL368805A1 (https=)
RU (1) RU2004103075A (https=)
WO (1) WO2003013610A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125127D0 (en) * 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
KR20040086370A (ko) 2002-02-13 2004-10-08 글락소 그룹 리미티드 계면활성제로서 사용되는 카르복실산 화합물
GB0323701D0 (en) * 2003-10-09 2003-11-12 Glaxo Group Ltd Formulations
WO2005099718A1 (en) * 2004-04-19 2005-10-27 Centre National De La Recherche Scientifique (C.N.R.S.) Lung surfactant supplements
CA2575297C (en) 2004-08-04 2014-09-23 Acea Biosciences, Inc. Method for assaying for natural killer, cytotoxic t-lymphocyte and neutrophil-mediated killing of target cells using real-time microelectronic cell sensing technology
DE102005000858A1 (de) * 2005-01-05 2006-07-20 Merck Patent Gmbh Fluortenside
PL240578B1 (pl) * 2018-10-26 2022-05-02 Nanosanguis Związek chemiczny będący solą amoniową częściowo fluorowanych kwasów organicznych oraz jego zastosowania

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250808A (en) * 1963-10-31 1966-05-10 Du Pont Fluorocarbon ethers derived from hexafluoropropylene epoxide
US3498923A (en) * 1966-10-18 1970-03-03 Us Navy Surface-active compositions and method for displacing liquid organic films from solid surfaces
JPS5331582A (en) 1976-09-04 1978-03-24 Daikin Ind Ltd Aerosol composition
US4346235A (en) * 1979-06-15 1982-08-24 Okamura Oil Mill Limited Fluorine-containing compounds
JPS62297478A (ja) 1986-06-18 1987-12-24 Nippon Soda Co Ltd 表面処理剤およびその製造方法
FR2613357B1 (fr) * 1987-04-06 1989-06-16 Atochem Trifluoromethylation de composes organiques insatures
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
AU654813B2 (en) * 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
NZ238749A (en) 1990-06-28 1993-07-27 Glaxo Inc Aerosol inhalation drug formulations with 1,1,1,2-tetrafluoroethane as propellant and a perfluorinated surfactant
JPH04283538A (ja) 1991-03-13 1992-10-08 Neos Co Ltd 含フッ素カルボン酸誘導体
JP2668760B2 (ja) 1992-06-02 1997-10-27 スカイアルミニウム 株式会社 アルカリ化学粗面化用アルミニウム合金展伸材およびその製造方法
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
DE19731300C1 (de) 1997-07-11 1999-01-21 Schering Ag Perfluoralkylgruppenhaltige Trijodaromaten, Verfahren zu deren Herstellung und deren Verwendung als Kontrastmittel
DE19731591C2 (de) 1997-07-17 1999-09-16 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers

Similar Documents

Publication Publication Date Title
KR100278339B1 (ko) 제약 에어로졸 제제
JP6087882B2 (ja) 薬用エアゾール製品
ES2274247T3 (es) Formulaciones para inhalacion.
JP2003518484A5 (https=)
JPH05505824A (ja) 所定投与量エアロゾル製剤の製造のための可溶性弗素界面活性剤の使用
CA2427282A1 (en) Mixtures or organic compounds for the treatment of airway diseases
JP2006528228A (ja) サルメテロール及びシクレソニドの組合せ物
RS76604A (sr) Inhalatori odmerene doze pod pritiskom koji sadrže rastvore beta-2-agonista
CA2421976A1 (en) Medicaments
JP2003518484A (ja) サルメテロールおよびプロピオン酸フルチカゾンの医薬用エアゾル製剤
JP2024525555A (ja) エアロゾル薬物送達のための組成物、方法および系
JP2008515508A5 (https=)
JP2000515536A (ja) エアゾール製剤
KR20240153567A (ko) 펜에틸아민 유도체, 조성물, 및 사용 방법
RU2565438C2 (ru) Фармацевтическая аэрозольная композиция
JP2005501082A5 (https=)
KR20240153566A (ko) 치료적 펜에틸아민 조성물, 및 사용 방법
JP2007523942A (ja) 加圧式定量吸入器のための安定な薬剤溶液配合物
CA2457717A1 (en) Use of compounds in a dry powder inhaler
JP2005514440A (ja) アミドおよび/またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物
JP2004529108A5 (https=)
JP2004500432A (ja) モメタゾンとサルメテロールを含む組合せ医薬
JP2002012541A (ja) フィルムコーティング組成物およびそれを用いた防臭性固形製剤
JP2004525920A5 (https=)
US20130160761A1 (en) Pharmaceutical Aerosol Composition